7th BCM-CUHK Joint Symposium in Clinical Genetics 2026
:quality(80))
The 7th BCM-CUHK Joint Symposium in Clinical Genetics 2026 will take place from 7–8 November 2026 in Hong Kong, bringing together global leaders in clinical genetics, genomics, and precision medicine to discuss the latest scientific discoveries and clinical applications transforming healthcare.
The scientific programme features keynote lectures, parallel scientific sessions, workshops, and industry symposia covering a broad range of topics, including genomic innovations, rare diseases, reproductive genetics, neurogenetics, AI-driven genomics, prenatal genome sequencing, and personalized medicine.
The symposium offers an excellent opportunity for learning, networking, and collaboration within the genetics and genomics community.
Oxford Nanopore is proud to be a sponsor of this year's symposium. Our team will be exhibiting throughout the meeting and hosting a dedicated Parallel Lunch Symposium, where attendees can learn about the latest advances and real-world applications of nanopore sequencing in clinical and translational genomics.
Visit the Oxford Nanopore booth to meet our team, explore our technology portfolio, and discover how long-read sequencing is helping address some of the most challenging questions in genomic medicine.
Oxford Nanopore Lunch Symposium
Sunday, 8 November | 12:30 - 13:30 | ||
|---|---|---|
Time | Agenda | Presenter |
12:30 – 12:55 | Utilizing non-invasive prenatal test sequencing data for medical genetic investigation | Dr. Siyang Liu |
12:55 – 13:20 | From nanopore reads to molecular classes: AI-guided methylome classification of CNS tumors | Dr. Yanghao Hou |
13:20 – 13:30 | Q & A session | All |
Speakers
:quality(80))
Siyang Liu, Sun Yat-sen University, the School of Public Health (Shenzhen), Dr. Liu is an Associate Professor and Ph.D. supervisor at the School of Public Health (Shenzhen), Sun Yat-sen University. Her group focused on human statistical genetics and bioinformatics research. Her expertise lies in the systematic analysis of key genes, genetic and evolutionary features, and causative environmental risk factors associated with human diseases and traits through bioinformatics, statistical, and machine learning algorithms. Her research aims to explore the molecular and systemic etiology of complex diseases and establish individual and population disease prediction and intervention models. Her major academic contributions include:
• Development of precise structural variation detection algorithms and elucidation of the frequency distribution and evolutionary patterns of structural variations in a pedigree population (co-first author in Nature, co-first author in Nature Communications, first author in GigaScience).
• Pioneering the use of large-scale ultra-low-depth sequencing data to investigate the genetics and molecular characteristics of complex diseases and quantitative traits, revealing the evolutionary history and plasma virus infection patterns in the Chinese population, and uncovering genes related to reproductive traits such as fertility age and twin pregnancy (first author in Cell).
Her work was published in high-profile journals such as CELL, NATURE, and Cell Discovery as a (co)-first or (co)-corresponding author and funded by the National Natural Science Foundation of China, Shenzhen Stable Support Fund, Guangdong Provincial Basic and Applied Basic Research Fund and National Key Research and Development Program.
:quality(80))
Yanghao Hou, School of Basic Medical Sciences, Chongqing Medical UniversityDr. Yanghao Hou is a neuropathologist and researcher specializing in DNA methylation profiling, multi-omics integration, and AI-driven classification of central nervous system (CNS) tumors. He earned his Doctor’s degree in Neuropathology from the Heidelberg University and completed subspecialty training in neuropathology in Germany. His research focuses on translating molecular and epigenetic profiling into clinical diagnostics, particularly for CNS tumors, with expertise in methylation array analysis, bioinformatics, and precision neuropathology. Dr. Hou has authored and co-authored publications in leading journals including Acta Neuropathological, Acta Neuropathological Communications, Brain Pathology, and Behavioural Brain Research, and has presented his work at major international conferences such as the European Association of Neuro-Oncology (EANO). He currently serves as a Lecturer in the Department of Pathology at Chongqing Medical University and is actively involved in national and international neuro-oncology and neuropathology professional organizations.
